Purpose: Purpose: Phosphodiesterase type 5 inhibitors (PDE5i) are widely used to treat erectile dysfunction (ED).However, a subset of men does not respond to these agents or seek restoration of natural erections.Regenerative therapies (RT), including lowintensity shock wave therapy (LiSWT), platelet-rich plasma (PRP) therapy, and stem cell therapy (SCT), have emerged as potential alternative treatment options.This article reviews the available evidence and presents the Global Andrology Forum (GAF) graded statements and recommendations for the use of RT in ED. Materials and Materials and Methods: Methods: A GAF expert panel conducted a literature review of the PubMed and Scopus databases up to February 2025 to identify studies on RT for ED.Surveys and a modified Delphi consensus method were employed to develop position statements and clinical recommendations.These were graded according to the "GRADE" classification system as either "strong" or "weak."Recommendations receiving strong ratings from at least 80% of experts were classified as "strong," while
Hamoda et al. (Thu,) studied this question.